These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12471061)

  • 1. Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
    Helmlinger D; Yvert G; Picaud S; Merienne K; Sahel J; Mandel JL; Devys D
    Hum Mol Genet; 2002 Dec; 11(26):3351-9. PubMed ID: 12471061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
    Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
    J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.
    Ragauskas S; Leinonen H; Puranen J; Rönkkö S; Nymark S; Gurevicius K; Lipponen A; Kontkanen O; Puoliväli J; Tanila H; Kalesnykas G
    PLoS One; 2014; 9(12):e113317. PubMed ID: 25469887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program.
    Abou-Sleymane G; Chalmel F; Helmlinger D; Lardenois A; Thibault C; Weber C; Mérienne K; Mandel JL; Poch O; Devys D; Trottier Y
    Hum Mol Genet; 2006 Mar; 15(5):691-703. PubMed ID: 16434483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
    Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
    Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6/1 mouse model of Huntington's disease.
    Batcha AH; Greferath U; Jobling AI; Vessey KA; Ward MM; Nithianantharajah J; Hannan AJ; Kalloniatis M; Fletcher EL
    Neurobiol Dis; 2012 Mar; 45(3):887-96. PubMed ID: 22198376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.
    Niu C; Prakash TP; Kim A; Quach JL; Huryn LA; Yang Y; Lopez E; Jazayeri A; Hung G; Sopher BL; Brooks BP; Swayze EE; Bennett CF; La Spada AR
    Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.
    Yvert G; Lindenberg KS; Picaud S; Landwehrmeyer GB; Sahel JA; Mandel JL
    Hum Mol Genet; 2000 Oct; 9(17):2491-506. PubMed ID: 11030754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inactivation of synaptic HRG4 (UNC119) causes dysfunction in the distal photoreceptor and slow retinal degeneration, revealing a new function.
    Ishiba Y; Higashide T; Mori N; Kobayashi A; Kubota S; McLaren MJ; Satoh H; Wong F; Inana G
    Exp Eye Res; 2007 Mar; 84(3):473-85. PubMed ID: 17174953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins.
    Ko J; Ou S; Patterson PH
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):319-29. PubMed ID: 11719267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac dysfunction in the R6/2 mouse model of Huntington's disease.
    Mihm MJ; Amann DM; Schanbacher BL; Altschuld RA; Bauer JA; Hoyt KR
    Neurobiol Dis; 2007 Feb; 25(2):297-308. PubMed ID: 17126554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy.
    Merienne K; Friedman J; Akimoto M; Abou-Sleymane G; Weber C; Swaroop A; Trottier Y
    Neurobiol Dis; 2007 Mar; 25(3):571-81. PubMed ID: 17189700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases.
    Friedrich B; Euler P; Ziegler R; Kuhn A; Landwehrmeyer BG; Luthi-Carter R; Weiller C; Hellwig S; Zucker B
    Brain Res; 2012 Oct; 1481():37-48. PubMed ID: 22917585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.
    Sathasivam K; Woodman B; Mahal A; Bertaux F; Wanker EE; Shima DT; Bates GP
    Hum Mol Genet; 2001 Oct; 10(21):2425-35. PubMed ID: 11689489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
    Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
    Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
    Milnerwood AJ; Cummings DM; Dallérac GM; Brown JY; Vatsavayai SC; Hirst MC; Rezaie P; Murphy KP
    Hum Mol Genet; 2006 May; 15(10):1690-703. PubMed ID: 16600988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization.
    Chen S; Peng GH; Wang X; Smith AC; Grote SK; Sopher BL; La Spada AR
    Hum Mol Genet; 2004 Jan; 13(1):53-67. PubMed ID: 14613968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
    Nguyen T; Hamby A; Massa SM
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11840-5. PubMed ID: 16087879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.